Coherus Biosciences reported $741.73M in Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acadia Pharmaceuticals ACAD:US $ 717.67M 6.76M
Aerie Pharmaceuticals AERI:US $ 351.8M 3.73M
Akebia Therapeutics AKBA:US $ 602.27M 9.6M
Alexion Pharmaceuticals ALXN:US $ 18650.2M 547.2M
ALKERMES ALKS:US $ 1995.43M 57.86M
Alnylam Pharmaceuticals ALNY:US $ 3472.31M 37.12M
Amarin AMRN:US $ 1035.8M 9.19M
Amgen AMGN:US $ 64993M 5220M
Baxter International BAX:US $ 19807M 125M
Biogen BIIB:US $ 23806.7M 663.7M
Biomarin Pharmaceutical BMRN:US $ 5977.48M 78.98M
Bluebird Bio BLUE:US $ 1339.64M 114.82M
Bristol Myers Squibb BMY:US $ 110893M 96M
Coherus Biosciences CHRS:US $ 741.73M 2.18M
Eli Lilly And LLY:US $ 48187M 378M
Endo International Ordinary Shares ENDP:US $ 9246.55M 40.3M
Fujifilm 4901:JP Y 3659304M 38280M
Gilead Sciences GILD:US $ 67098M 886M
Horizon Pharma HZNP:US $ 8608.69M 401.27M
Ironwood Pharmaceuticals IRWD:US $ 1079.37M 72.15M
JAZZ PHA JAZZ:US $ 12478.15M 734.84M
LG Chem 051910:KS KW 49821983M 3086974M
Myriad Genetics MYGN:US $ 1335.9M 24.4M
Pacira Pharmaceuticals PCRX:US $ 1356M 30.17M
Perrigo Ordinary Shares PRGO:US $ 10915.9M 314.4M
Ptc Therapeutics PTCT:US $ 2007.32M 51.34M
Regeneron Pharmaceuticals REGN:US $ 23671.5M 2185.6M
Revance Therapeutics RVNC:US $ 581.83M 59.05M
Sarepta Therapeutics SRPT:US $ 2662.22M 96.86M
Teva Pharmaceutical TEVA:IT 47.85B 1.34B
Vertex Pharmaceuticals VRTX:US $ 12618.74M 397.06M
Xencor XNCR:US $ 697.26M 1.66M
Zoetis ZTS:US $ 13705M 364M